Cybin (CYBN.NE) has selected social anxiety disorder (SAD) and generalized anxiety disorder (GAD) as the targets for their CYB004 proprietary psychedelic molecule. Cybin demonstrated their proof of concept for…
Latest News
Top 5 Gainers and Losers: RHC.V, VG.V, PEI.V
Top 5 Gainers and Losers: KASH.CN, QIMC.CN, TGH.V
Zentek (ZEN.V) took a years long path to figure out its incredible biotech potential
Tesla stock to $100?
Top 5 Gainers and Losers: KASH.CN, DHR.V, BRO.V
Standard Uranium (STND.V) looks to add to Sun Dog’s uranium history